|
Market Closed -
Bombay S.E.
10:02:27 03/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 8.750 INR | +6.58% |
|
-1.46% | -38.81% |
| 10-01 | Gennex Laboratories Limited Announces Board Changes | CI |
| 08-14 | Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1.99B 21.07M 18.81M 17.26M 15.7M 29.44M 30.03M 206M 83.11M 1.05B 79.07M 77.39M 3.33B | P/E 2025 |
15.4x | P/E 2026 | 8.26x |
|---|---|---|---|---|---|
| Enterprise Value | 2.41B 25.5M 22.77M 20.89M 19M 35.63M 36.34M 250M 101M 1.27B 95.7M 93.66M 4.02B | EV / Sales 2025 |
1.79x | EV / Sales 2026 | 1.25x |
| Free-Float |
66.61% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | +6.58% | ||
| 1 week | -1.46% | ||
| Current month | +9.10% | ||
| 1 month | -11.62% | ||
| 3 months | -3.31% | ||
| 6 months | -13.71% | ||
| Current year | -38.81% |
| 1 week | 7.7 | 9.21 | |
| 1 month | 7.7 | 10.25 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 16.3 | |
| 3 years | 7.05 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 | |
| Director/Board Member | 62 | 30/09/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +6.58% | -1.46% | -43.40% | -22.29% | 21.07M | ||
| +1.33% | +11.79% | +59.85% | +152.39% | 1,257B | ||
| -0.33% | +0.59% | +45.13% | +78.61% | 651B | ||
| +0.30% | +1.62% | +37.31% | +105.79% | 510B | ||
| -0.31% | -0.53% | +52.95% | +67.29% | 388B | ||
| -1.66% | +3.56% | +78.05% | +42.07% | 366B | ||
| +0.71% | +2.97% | +33.27% | +59.11% | 303B | ||
| +0.39% | +8.35% | +12.36% | +35.27% | 288B | ||
| +0.20% | +4.09% | +57.37% | +72.79% | 252B | ||
| +0.50% | +7.54% | +40.17% | +109.67% | 211B | ||
| Average | +0.84% | +3.69% | +37.30% | +70.07% | 422.67B | |
| Weighted average by Cap. | +0.41% | +5.30% | +49.52% | +96.48% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.38B 14.57M 13.01M 11.93M 10.86M 20.35M 20.76M 143M 57.46M 728M 54.67M 53.5M 2.3B | 1.73B 18.25M 16.29M 14.95M 13.6M 25.5M 26M 179M 71.97M 912M 68.48M 67.02M 2.88B |
| Net income | 181M 1.91M 1.71M 1.57M 1.43M 2.67M 2.73M 18.73M 7.55M 95.65M 7.18M 7.03M 302M | 210M 2.22M 1.98M 1.82M 1.65M 3.1M 3.16M 21.68M 8.74M 111M 8.32M 8.14M 350M |
| Net Debt | -275M -2.9M -2.59M -2.38M -2.16M -4.06M -4.14M -28.4M -11.45M -145M -10.89M -10.66M -458M | 420M 4.43M 3.96M 3.63M 3.3M 6.19M 6.31M 43.36M 17.48M 221M 16.63M 16.28M 699M |
Employees
125
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/11/26 | ₹8.750 | +6.58% | 321,525 |
| 02/11/26 | ₹8.210 | +2.37% | 1,053,207 |
| 30/10/26 | ₹8.020 | -10.49% | 1,321,688 |
| 29/10/26 | ₹8.960 | -1.54% | 188,622 |
| 28/10/26 | ₹9.100 | +2.48% | 286,354 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















